In order to test which cell population predominantly expresses SPARC mRNA, we separated PBMCs of 4 HC and 4 CML patients, the latter at diagnosis and after 3 months of IM therapy. This evidence concerns the gene SPARC and chronic myelogenous leukemia, BCR-ABL1 positive.